Filter
419
Text search:
genome
Featured
Recommendations
51
New Publications
75
Language
Document type
No document type
157
Studies & Reports
104
Guidelines
83
Manuals
29
Strategic & Response Plan
14
Fact sheets
13
Training Material
10
Situation Updates
4
Resource Platforms
4
Infographics
1
Countries / Regions
India
20
Global
19
Latin America and the Carribbean
11
Western and Central Europe
10
Russia
9
Germany
8
Tanzania
8
South Africa
7
Nigeria
5
Brazil
5
Ukraine
5
Africa
5
Eastern Europe
5
Uganda
4
Ethiopia
3
Chad
3
Middle East and North Africa
3
South–East Asia Region
3
Liberia
2
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Ghana
2
Niger
2
Haiti
2
South Sudan
2
Kenya
2
Peru
2
Colombia
2
Bolivia
2
Angola
2
West and Central Africa
2
Western Pacific Region
2
Venezuela
2
France
2
Spain
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Morocco
1
USA
1
Saudi Arabia
1
Philippines
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Syria
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
Mauritania
1
Bangladesh
1
Malawi
1
Mozambique
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
Eastern Europe and Central Asia
1
Asia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Denmark
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
58
Public Health
20
Key Resources
15
Pharmacy & Technologies
15
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
69
NTDs
60
TB
47
Rapid Response
29
AMR
29
Mental Health
23
Zika
15
HIV
15
2.0 Rapid Response
13
Ebola & Marburg
11
Planetary Health
11
Refugee
8
NCDs
8
Polio
6
Conflict
4
Global Health Education
4
Caregiver
4
Malaria
4
Disability
3
Specific Hazards
3
Health Financing Toolbox
3
Cholera
2
Pharmacy
2
South Sudan
1
Natural Hazards
1
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by
...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ
...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
PLoS Negl Trop Dis 18(7): e0012282.
This review highlights common diagnostic
approaches for detecting schistosomiasis in field and clinical settings, major challenges,
and provides new and novel opportunities and diagnosis pathways that will be critical in sup-
porting elimination of schistosomi
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Infectious Diseases of Poverty (2020) 9:74
To detect acute schistosomiasis, low-intensity infections, or to verify the success of treatment with
praziquantel, highly sensitive test methods are required. The aim of this study was therefore to demonstrate the
performance of Schistosoma mansoni spec
...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 5-11 November 2017 and includes updates on measles, rubella, chikungunya, West Nile virus, Plague, monkeypox, legionnair
...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
